Maxcyte (MXCT) Finished Goods (2020 - 2026)

Maxcyte (MXCT) has reported Finished Goods for 7 consecutive years, with $3.6 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Finished Goods rose 4.31% year-over-year to $3.6 million in Q2 2026; TTM through Jun 2026 was $3.6 million, a 4.31% increase from a year earlier, with the FY2025 full-year figure at $3.2 million, down 18.97% from the prior year.
• Finished Goods was $3.6 million for Q2 2026 at Maxcyte, up from $3.5 million in the prior quarter.
• Over five years, Finished Goods peaked at $6.0 million in Q1 2024 and troughed at $2.7 million in Q3 2022.
• A 5-year average of $4.0 million and a median of $3.6 million in 2023 frame the typical range for Finished Goods.
• Across the five-year window, Finished Goods surged 121.46% in 2023 and slumped 40.19% in 2025, its largest moves.
• Over 5 years, Finished Goods stood at $2.9 million in 2022, then surged by 103.99% to $6.0 million in 2023, then slumped by 34.3% to $3.9 million in 2024, then fell by 18.97% to $3.2 million in 2025, then increased by 13.98% to $3.6 million in 2026.
• The last three Finished Goods figures came in at $3.6 million (Q2 2026), $3.5 million (Q1 2026), and $3.2 million (Q4 2025), per Business Quant data.